EE05068B1 - 4''-asendatud- 9-deokso-9A-asa-9A-homoertromtsiini derivaadi difosfaatsool ja selle farmatseutiline kompositsioon - Google Patents

4''-asendatud- 9-deokso-9A-asa-9A-homoertromtsiini derivaadi difosfaatsool ja selle farmatseutiline kompositsioon

Info

Publication number
EE05068B1
EE05068B1 EEP200100699A EEP200100699A EE05068B1 EE 05068 B1 EE05068 B1 EE 05068B1 EE P200100699 A EEP200100699 A EE P200100699A EE P200100699 A EEP200100699 A EE P200100699A EE 05068 B1 EE05068 B1 EE 05068B1
Authority
EE
Estonia
Prior art keywords
thromcine
homoeric
deoxo
aza
derivative
Prior art date
Application number
EEP200100699A
Other languages
English (en)
Inventor
John Rafka Robert
Brendan Ragan Colman
John Meldrum Allen Douglas
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200100699A publication Critical patent/EE200100699A/et
Publication of EE05068B1 publication Critical patent/EE05068B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200100699A 1999-06-30 2000-06-13 4''-asendatud- 9-deokso-9A-asa-9A-homoertromtsiini derivaadi difosfaatsool ja selle farmatseutiline kompositsioon EE05068B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14168199P 1999-06-30 1999-06-30
PCT/IB2000/000785 WO2001002414A1 (en) 1999-06-30 2000-06-13 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Publications (2)

Publication Number Publication Date
EE200100699A EE200100699A (et) 2003-02-17
EE05068B1 true EE05068B1 (et) 2008-08-15

Family

ID=22496734

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100699A EE05068B1 (et) 1999-06-30 2000-06-13 4''-asendatud- 9-deokso-9A-asa-9A-homoertromtsiini derivaadi difosfaatsool ja selle farmatseutiline kompositsioon

Country Status (42)

Country Link
US (3) US6465437B1 (et)
EP (1) EP1189913B1 (et)
JP (1) JP2003503506A (et)
KR (1) KR100442508B1 (et)
CN (2) CN101220067A (et)
AP (1) AP2001002370A0 (et)
AR (1) AR035551A1 (et)
AT (1) ATE286906T1 (et)
AU (1) AU772277B2 (et)
BG (1) BG65587B1 (et)
BR (1) BR0012091A (et)
CA (1) CA2376748C (et)
CO (1) CO5190679A1 (et)
CZ (1) CZ20014571A3 (et)
DE (1) DE60017399T2 (et)
EA (1) EA004235B1 (et)
EC (1) ECSP003555A (et)
EE (1) EE05068B1 (et)
ES (1) ES2233380T3 (et)
GT (2) GT200000105A (et)
HN (1) HN2000000090A (et)
HR (1) HRP20010919B1 (et)
HU (1) HUP0201693A3 (et)
IL (1) IL146408A0 (et)
IS (1) IS6159A (et)
MA (1) MA26745A1 (et)
MX (1) MXPA02000058A (et)
MY (1) MY133360A (et)
NO (1) NO20016221L (et)
OA (1) OA11965A (et)
PA (1) PA8496901A1 (et)
PE (1) PE20010287A1 (et)
PL (1) PL201891B1 (et)
PT (1) PT1189913E (et)
SK (1) SK286243B6 (et)
TN (1) TNSN00143A1 (et)
TR (1) TR200103834T2 (et)
UA (1) UA71013C2 (et)
UY (1) UY26221A1 (et)
WO (1) WO2001002414A1 (et)
YU (1) YU88701A (et)
ZA (1) ZA200110453B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6791660B1 (en) * 2002-02-12 2004-09-14 Seiko Epson Corporation Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN110885351A (zh) * 2019-12-17 2020-03-17 海门慧聚药业有限公司 泰拉霉素磷酸盐的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
IL145946A0 (en) * 1999-05-18 2002-07-25 Pfizer Prod Inc Novel crystalline forms of a macrolide antibiotic
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

Also Published As

Publication number Publication date
GT200000105A (es) 2001-12-20
ES2233380T3 (es) 2005-06-16
KR100442508B1 (ko) 2004-07-30
NO20016221D0 (no) 2001-12-19
GT200000105AA (es) 2001-12-20
AU4943900A (en) 2001-01-22
CN101220067A (zh) 2008-07-16
YU88701A (sh) 2004-09-03
HRP20010919A2 (en) 2003-02-28
EP1189913B1 (en) 2005-01-12
MA26745A1 (fr) 2004-12-20
TNSN00143A1 (fr) 2005-11-10
NO20016221L (no) 2001-12-19
SK286243B6 (sk) 2008-06-06
HUP0201693A3 (en) 2003-03-28
US20030092642A1 (en) 2003-05-15
PT1189913E (pt) 2005-04-29
US6465437B1 (en) 2002-10-15
DE60017399T2 (de) 2006-03-30
EE200100699A (et) 2003-02-17
IS6159A (is) 2001-11-13
EP1189913A1 (en) 2002-03-27
AR035551A1 (es) 2004-06-16
US7297682B2 (en) 2007-11-20
MY133360A (en) 2007-11-30
BG106123A (en) 2002-05-31
EA200101178A1 (ru) 2002-06-27
CN1358188A (zh) 2002-07-10
JP2003503506A (ja) 2003-01-28
PL352900A1 (en) 2003-09-22
CO5190679A1 (es) 2002-08-29
CA2376748C (en) 2006-03-14
ECSP003555A (es) 2002-01-25
UA71013C2 (uk) 2004-11-15
HN2000000090A (es) 2001-04-20
KR20020016875A (ko) 2002-03-06
TR200103834T2 (tr) 2002-05-21
EA004235B1 (ru) 2004-02-26
US6861412B2 (en) 2005-03-01
IL146408A0 (en) 2002-07-25
HRP20010919B1 (en) 2005-06-30
ATE286906T1 (de) 2005-01-15
US20040209826A1 (en) 2004-10-21
HUP0201693A2 (en) 2002-10-28
BG65587B1 (bg) 2009-01-30
UY26221A1 (es) 2001-01-31
BR0012091A (pt) 2002-04-02
PL201891B1 (pl) 2009-05-29
DE60017399D1 (de) 2005-02-17
SK18922001A3 (sk) 2002-04-04
CZ20014571A3 (cs) 2002-04-17
OA11965A (en) 2006-04-12
ZA200110453B (en) 2003-03-04
AP2001002370A0 (en) 2001-12-31
AU772277B2 (en) 2004-04-22
PA8496901A1 (es) 2002-08-26
CA2376748A1 (en) 2001-01-11
PE20010287A1 (es) 2001-03-05
MXPA02000058A (es) 2002-07-02
WO2001002414A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
EE04904B1 (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
PT1066027E (pt) Composicao farmaceutica de topiramato
FI970825A (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
PT907364E (pt) Composicao farmaceutica de libertacao sustida
NO996372L (no) Fast farmasøytisk preparat inneholdende benzofuanderivater
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
EE04954B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
DE69618663D1 (de) O-carbamoyl-phenylalaninol-zusammensetzungen und ihre pharmazeutisch anwendbaren salzen
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
PT1077681E (pt) Composicao farmaceutica contendo levotiroxina sodio
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
EE200100699A (et) 4''-asendatud- 9-deokso-9A-asa-9A-homoerütromütsiini derivaadi difosfaatsool ja selle farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
EE05317B1 (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
EE05262B1 (et) Leptiini v?i selle homoloogi v?i derivaadi kasutamine, farmatseutiline kompositsioon ja segu
DE69900336D1 (de) Pentoxifyllin und antizytokin enthaltende pharmazeutische zusammensetzungen
ID23531A (id) Komposisi farmasi
SI1189913T1 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
IS6160A (is) Dífosfat salt af 4"-setinni-9-deoxó-9A-asa-9A-hómóerýtrómysín afleiðu og lyfjasamsetning þar af

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090613